Nyt fra tidsskrifterne
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
47 ud af 47 tidsskrifter valgt, ingen søgeord valgt, emner højest 7 dage gamle, sorteret efter nyeste først.
262 emner vises.
Michelle Morse
Lancet, 8.12.2023
Tilføjet 8.12.2023
The phrase, “the pandemic is a portal” has been repeated endlessly since the COVID-19 pandemic began, sometimes as a meditation, other times as a demand, and occasionally as a statement of fact. But now, as societies move on in the wake of the pandemic, where are we in this portal? The answer depends largely on your theory of change and your role in the intersecting social movements that have engaged in dialogue and action around the expansive global and local injustices related to the pandemic and the inequities it highlighted.
Læs mere Tjek på PubMedTobias Kasper, Gavin Yamey, Sinead Dwyer, Kaci Kennedy McDade, Jon Lidén, Cora Lüdemann, Mohamed Mustafa Diab, Osondu Ogbuoji, Prashant Poodla, Christina Schrade, Andrea Thoumi, Armand Zimmerman, Yibeltal Assefa, Luke N Allen, Paulin Basinga, Patricia J Garcia, Debra Jackson, Henry Mwanyika, Rachel Nugent, Anthony Ofosu, Salman Rawaf, K Srinath Reddy, Dykki Settle, Beth Tritter, Christoph Benn
Lancet, 8.12.2023
Tilføjet 8.12.2023
Global campaigns to control HIV, tuberculosis, malaria, and vaccine-preventable illnesses showed that large-scale impact can be achieved by using additional international financing to support selected, evidence-based, high-impact investment areas and to catalyse domestic resource mobilisation. Building on this paradigm, we make the case for targeting additional international funding for selected high-impact investments in primary health care. We have identified and costed a set of concrete, evidence-based investments that donors could support, which would be expected to have major impacts at an affordable cost.
Læs mere Tjek på PubMedNambusi Kyegombe, Gbolahan Ajibola, Maureen Sakoi-Mosetlhi, Tsholofelo Rebatenne, Motswedi Anderson, Simani Gaseitsiwe, Joseph Makhema, Una Ngwenya, Sikhulile Moyo, Odile Sauzet, Lucy Mupfumi
PLoS One Infectious Diseases, 8.12.2023
Tilføjet 8.12.2023
by Nambusi Kyegombe, Gbolahan Ajibola, Maureen Sakoi-Mosetlhi, Tsholofelo Rebatenne, Motswedi Anderson, Simani Gaseitsiwe, Joseph Makhema, Una Ngwenya, Sikhulile Moyo, Odile Sauzet, Lucy Mupfumi
Læs mere Tjek på PubMedArsenio De La Vega Sánchez, Ana Navas Pérez, Marcos Pérez-Carrasco, María Torrens Sonet, Yolanda Diaz Buendia, Patricia Ortiz Ballujera, Miguel Rodríguez López, Joan Sabater Riera, Aitor Olmo-Isasmendi, Ester Vendrell Torra, María Álvarez García-Pumarino, Mercedes Ibarz Villamayor, Rosa María Catalán Ibars, Iban Oliva Zelaya, Javier Pardos Chica, Conxita Rovira Anglès, Teresa M. Tomasa-Irriguible, Anna Baró Serra, Edward J. Casanova, Francisco J. González De Molina, on behalf of The AKICOV Group
PLoS One Infectious Diseases, 8.12.2023
Tilføjet 8.12.2023
by Arsenio De La Vega Sánchez, Ana Navas Pérez, Marcos Pérez-Carrasco, María Torrens Sonet, Yolanda Diaz Buendia, Patricia Ortiz Ballujera, Miguel Rodríguez López, Joan Sabater Riera, Aitor Olmo-Isasmendi, Ester Vendrell Torra, María Álvarez García-Pumarino, Mercedes Ibarz Villamayor, Rosa María Catalán Ibars, Iban Oliva Zelaya, Javier Pardos Chica, Conxita Rovira Anglès, Teresa M. Tomasa-Irriguible, Anna Baró Serra, Edward J. Casanova, Francisco J. González De Molina, on behalf of The AKICOV Group
Læs mere Tjek på PubMedJohn Efromson, Giuliano Ferrero, Aurélien Bègue, Thomas Jedidiah Jenks Doman, Clay Dugo, Andi Barker, Veton Saliu, Paul Reamey, Kanghyun Kim, Mark Harfouche, Jeffrey A. Yoder
PLoS One Infectious Diseases, 8.12.2023
Tilføjet 8.12.2023
by John Efromson, Giuliano Ferrero, Aurélien Bègue, Thomas Jedidiah Jenks Doman, Clay Dugo, Andi Barker, Veton Saliu, Paul Reamey, Kanghyun Kim, Mark Harfouche, Jeffrey A. Yoder Normal development of the immune system is essential for overall health and disease resistance. Bony fish, such as the zebrafish (Danio rerio), possess all the major immune cell lineages as mammals and can be employed to model human host response to immune challenge. Zebrafish neutrophils, for example, are present in the transparent larvae as early as 48 hours post fertilization and have been examined in numerous infection and immunotoxicology reports. One significant advantage of the zebrafish model is the ability to affordably generate high numbers of individual larvae that can be arrayed in multi-well plates for high throughput genetic and chemical exposure screens. However, traditional workflows for imaging individual larvae have been limited to low-throughput studies using traditional microscopes and manual analyses. Using a newly developed, parallelized microscope, the Multi-Camera Array Microscope (MCAM™), we have optimized a rapid, high-resolution algorithmic method to count fluorescently labeled cells in zebrafish larvae in vivo. Using transgenic zebrafish larvae, in which neutrophils express EGFP, we captured 18 gigapixels of images across a full 96-well plate, in 75 seconds, and processed the resulting datastream, counting individual fluorescent neutrophils in all individual larvae in 5 minutes. This automation is facilitated by a machine learning segmentation algorithm that defines the most in-focus view of each larva in each well after which pixel intensity thresholding and blob detection are employed to locate and count fluorescent cells. We validated this method by comparing algorithmic neutrophil counts to manual counts in larvae subjected to changes in neutrophil numbers, demonstrating the utility of this approach for high-throughput genetic and chemical screens where a change in neutrophil number is an endpoint metric. Using the MCAM™ we have been able to, within minutes, acquire both enough data to create an automated algorithm and execute a biological experiment with statistical significance. Finally, we present this open-source software package which allows the user to train and evaluate a custom machine learning segmentation model and use it to localize zebrafish and analyze cell counts within the segmented region of interest. This software can be modified as needed for studies involving other zebrafish cell lineages using different transgenic reporter lines and can also be adapted for studies using other amenable model species.
Læs mere Tjek på PubMedLinda J. Paul, Aaron C. Ericsson, Frank M. Andrews, Zachary McAdams, Michael L. Keowen, Michael P. St Blanc, Heidi E. Banse
PLoS One Infectious Diseases, 8.12.2023
Tilføjet 8.12.2023
by Linda J. Paul, Aaron C. Ericsson, Frank M. Andrews, Zachary McAdams, Michael L. Keowen, Michael P. St Blanc, Heidi E. Banse Equine glandular gastric disease (EGGD) is a common disease among athletic horses that can negatively impact health and performance. The pathophysiology of this EGGD remains poorly understood. Previous studies using controlled populations of horses identified differences in the gastric glandular mucosal microbiome associated with disease. The objective of this study was to compare the gastric microbiome in horses with EGGD and those without across multiple barns and differing management practices. We hypothesized that alterations in the microbiome of the gastric glandular mucosa are associated with EGGD. A secondary objective was to perform a risk factor analysis for EGGD using the diet and management data collected. Microbial populations of biopsies from normal pyloric mucosa of horses without EGGD (control biopsies), normal pyloric mucosa of horses with EGGD (normal biopsies) and areas of glandular mucosal disruption in horses with EGGD (lesion biopsies) were compared. Lesion biopsies had a different microbial community structure than control biopsies. Control biopsies had a higher read count for the phylum Actinomycetota compared to lesion biopsies. Control biopsies also had an enrichment of the genera Staphylococcus and Lawsonella and the species Streptococcus salivarius. Lesion biopsies had an enrichment of the genera Lactobacillus and Actinobacillus and the species Lactobacillus equigenerosi. These results demonstrate differences in the gastric glandular microbiome between sites of disrupted mucosa in horses with EGGD compared to pyloric mucosa of horses without EGGD. Risk factor analysis indicated that exercise duration per week was a risk factor for EGGD.
Læs mere Tjek på PubMedJing Liu, Xiaogang Hu
PLoS One Infectious Diseases, 8.12.2023
Tilføjet 8.12.2023
by Jing Liu, Xiaogang Hu Background Inflammation is involved in the development and progression of atherosclerosis. Recent studies indicated that glucose-to-lymphocyte ratio (GLR) level were significantly associated with the risk of mortality from inflammatory diseases, and showed a specific prognostic value. Herein, this study intended to explore the association between GLR level and in-hospital mortality in patients with acute myocardial infarction (AMI), and evaluate the predictive value of GLR on AMI prognosis. Methods Data of patients with AMI were extracted from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database in 2012–2019 in this retrospective cohort study. Univariate COX proportional hazard model was used to screen covariates. The associations between GLR and in-hospital mortality were evaluated using univariate and multivariate COX proportional hazard models. Subgroup analysis of age, gender, vasopressor use, SOFA scores, renal replacement therapy, coronary artery bypass graft, and β blockers use were performed. The evaluated index was hazard ratios (HRs) and 95% confidence intervals (CIs). In addition, the predictive performance of GLR, glucose, and lymphocytes on in-hospital mortality was assessed respectively. Results Among eligible patients, 248 (13.74%) died in the hospital. After adjusting for covariates, we found that a higher GLR level was associated with an increased risk of in-hospital mortality [HR = 1.70, 95%CI: (1.24–2.34)]. This relationship was also found in patients who were male, aged ≥65 years old, did not have renal replacement therapy, coronary artery bypass graft, or β blockers, used vasopressor or not, and whatever the SOFA scores (all P
Læs mere Tjek på PubMedSe Eun Kim, So Hee Park, Woo-Jung Park, Gayeong Kim, Seo Yeon Kim, Hyeran Won, Yun-Ho Hwang, Heeji Lim, Hyeon Guk Kim, You-Jin Kim, Dokeun Kim, Jung-Ah Lee
PLoS One Infectious Diseases, 8.12.2023
Tilføjet 8.12.2023
by Se Eun Kim, So Hee Park, Woo-Jung Park, Gayeong Kim, Seo Yeon Kim, Hyeran Won, Yun-Ho Hwang, Heeji Lim, Hyeon Guk Kim, You-Jin Kim, Dokeun Kim, Jung-Ah Lee Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in 2019 and caused the coronavirus disease 2019 (COVID-19) pandemic worldwide. As of September 2023, the number of confirmed coronavirus cases has reached over 770 million and caused nearly 7 million deaths. The World Health Organization assigned and informed the characterization of variants of concern (VOCs) to help control the COVID-19 pandemic through global monitoring of circulating viruses. Although many vaccines have been proposed, developing an effective vaccine against variants is still essential to reach the endemic stage of COVID-19. We designed five DNA vaccine candidates composed of the first isolated genotype and major SARS-CoV-2 strains from isolated Korean patients classified as VOCs, such as Alpha, Beta, Gamma, and Delta. To evaluate the immunogenicity of each genotype via homologous and heterologous vaccination, mice were immunized twice within a 3-week interval, and the blood and spleen were collected 1 week after the final vaccination to analyze the immune responses. The group vaccinated with DNA vaccine candidates based on the S genotype and the Alpha and Beta variants elicited both humoral and cellular immune responses, with higher total IgG levels and neutralizing antibody responses than the other groups. In particular, the vaccine candidate based on the Alpha variant induced a highly diverse cytokine response. Additionally, we found that the group subjected to homologous vaccination with the S genotype and heterologous vaccination with S/Alpha induced high total IgG levels and a neutralization antibody response. Homologous vaccination with the S genotype and heterologous vaccination with S/Alpha and S/Beta significantly induced IFN-γ immune responses. The immunogenicity after homologous vaccination with S and Alpha and heterologous vaccination with the S/Alpha candidate was better than that of the other groups, indicating the potential for developing novel DNA vaccines against different SARS-CoV-2 variants.
Læs mere Tjek på PubMedTsung-Jung Ho, Ching-Fang Lin, Jhong-Kuei Chen, Yen-Lun Kung, Li-Kung Wu, Chen-Ying Chang Chien, Chun-Ping Huang
PLoS One Infectious Diseases, 8.12.2023
Tilføjet 8.12.2023
by Tsung-Jung Ho, Ching-Fang Lin, Jhong-Kuei Chen, Yen-Lun Kung, Li-Kung Wu, Chen-Ying Chang Chien, Chun-Ping Huang Pain is strongly associated with neuro-immune activation. Thus, the emerging role of the endocannabinoid system in neuro-inflammation is important. Acupuncture has been used for over 2500 years and is widely accepted for the management of pain. Our study aimed to investigate the effects of electroacupuncture on the regulation of cannabinoid receptor type 1 within the peripheral nervous system. Inflammatory pain was induced by injecting Complete Freund’s adjuvant to induce mechanical and thermal hyperalgesia. Electroacupuncture significantly attenuated the mechanical and thermal sensitivities, and AM251, a cannabinoid receptor type 1 antagonist, eliminated these effects. Dual immunofluorescence staining demonstrated that electroacupuncture elevated expression of cannabinoid receptor type 1, co-localized with Nav 1.8. Furthermore, electroacupuncture significantly reduced levels of Nav 1.8 and COX-2 by western blot analysis, but not vice versa as AM251 treatment. Our data indicate that electroacupuncture mediates antinociceptive effects through peripheral endocannabinoid system signaling pathway and provide evidence that electroacupuncture is beneficial for pain treatment.
Læs mere Tjek på PubMedMalaria Journal, 8.12.2023
Tilføjet 8.12.2023
Abstract Background The use of primaquine for mass drug administration (MDA) is being considered as a key strategy for malaria elimination. In addition to being the only drug active against the dormant and relapsing forms of Plasmodium vivax, primaquine is the sole potent drug against mature/infectious Plasmodium falciparum gametocytes. It may prevent onward transmission and help contain the spread of artemisinin resistance. However, higher dose of primaquine is associated with the risk of acute haemolytic anaemia in individuals with a deficiency in glucose-6-phosphate dehydrogenase. In many P. falciparum endemic areas there is paucity of information about the distribution of individuals at risk of primaquine-induced haemolysis at higher dose 45 mg of primaquine. Methods A retrospective cross-sectional study was carried out using archived samples to establish the prevalence of G6PD deficiency in a malaria hotspot area in Misungwi district, located in Mwanza region, Tanzania. Blood samples collected from individuals recruited between August and November 2010 were genotyped for G6PD deficiency and submicroscopic parasites carriage using polymerase chain reaction. Results A total of 263 individuals aged between 0 and 87 were recruited. The overall prevalence of the X-linked G6PD A− mutation was 83.7% (220/263) wild type, 8% (21/263) heterozygous and 8.4% (22/263) homozygous or hemizygous. Although, assessment of the enzymatic activity to assign the phenotypes according to severity and clinical manifestation as per WHO was not carried out, the overall genotype and allele frequency for the G6PD deficiency was 16.4% and 13. 2%, respectively. There was no statistically significant difference in among the different G6PD genotypes (p > 0.05). Out of 248 samples analysed for submicroscopic parasites carriage, 58.1% (144/248) were P. falciparum positive by PCR. G6PD heterozygous deficiency were associated with carriage of submicroscopic P. falciparum (p = 0.029). Conclusions This study showed that 16.4% of the population in this part of North-western Tanzania carry the G6PD A− mutation, within the range of 15–32% seen in other parts of Africa. G6PD gene mutation is widespread and heterogeneous across the study area where primaquine would be valuable for malaria control and elimination. The maps and population estimates presented here reflect potential risk of higher dose of primaquine being associated with the risk of acute haemolytic anaemia (AHA) in individuals with a deficiency in glucose-6-phosphate dehydrogenase and call further research on mapping of G6PD deficiency in Tanzania. Therefore, screening and education programmes for G6PD deficiency is warranted in a programme of malaria elimination using a higher primaquine dose.
Læs mere Tjek på PubMedRosen, Joseph G.; Knox, Justin R.; Rucinski, Katherine B.; Mcingana, Mfezi; Mulumba, Ntambue; Comins, Carly A.; Shipp, Lillian; Makama, Siyanda; Beckham, S. Wilson; Hausler, Harry; Baral, Stefan D.; Schwartz, Sheree R.
Journal of Acquired Immune Deficiency Syndromes, 8.12.2023
Tilføjet 8.12.2023
Background: Given intersecting social and structural factors, female sex workers (FSW) exhibit elevated risk of HIV and substance use. However, there is limited study of how distinct substance use typologies influence HIV treatment outcomes among FSW. Setting: A cross-sectional survey with objective viral load assessments of 1,391 FSW enrolled into a treatment optimization-focused trial in Durban, South Africa (2018-2020). Methods: We used latent class analysis to uncover discrete patterns in past-month self-reported use of the following substances: heavy alcohol use, cannabis, cocaine, crack, ecstasy, methamphetamine, heroin, and whoonga. We used Wald tests to identify multilevel predictors of latent class membership and multivariable mixture modeling to quantify associations of substance use classes with HIV viremia (>50 RNA copies/mL). Results: Substance use (87%) and HIV viremia (62%) were highly prevalent. LCA uncovered three polysubstance use profiles: Heavy Alcohol Use Only (∼54%); Cannabis, Heavy Alcohol, & Crack Use (∼28%); and Whoonga & Crack Use (∼18%). Whoonga & Crack Use was associated with social and structural adversities, including homelessness, outdoor/public sex work, HIV stigma, and violence. Relative to Heavy Alcohol Use Only, HIV viremia was significantly higher in the Whoonga & Crack Use class (adjusted odds ratio [adjOR] 1.97, 95% confidence interval [95%CI] 1.13-3.43) but not in the Cannabis, Heavy Alcohol, & Crack Use class (adjOR 1.17, 95%CI 0.74-1.86). Conclusion: HIV viremia differed significantly across identified polysubstance use profiles among South African FSW. Integrating drug treatment and harm reduction services into HIV treatment programs is key to improving virologic outcomes in marginalized communities. Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Læs mere Tjek på PubMedBearden, David R.; Mwanza-Kabaghe, Sylvia; Bositis, Christopher M.; Dallah, Ifunanya; Johnson, Brent A.; Siddiqi, Omar K.; Elafros, Melissa A.; Gelbard, Harris A.; Okulicz, Jason F.; Kalungwana, Lisa; Musonda, Nkhoma; Theodore, William H.; Mwenechanya, Musaku; Mathews, Manoj; Sikazwe, Izukanji T.; Birbeck, Gretchen L.
Journal of Acquired Immune Deficiency Syndromes, 8.12.2023
Tilføjet 8.12.2023
Background: Seizures are relatively common among children with HIV in low-and middle-income countries, and are associated with significant morbidity and mortality. Early treatment with antiretroviral therapy may reduce this risk by decreasing rates of central nervous system infections and HIV encephalopathy. Methods: We conducted a prospective, unmatched case-control study. We enrolled children with new-onset seizure from University Teaching Hospital in Lusaka, Zambia as well as two regional hospitals in rural Zambia. Controls were children with HIV and no history of seizures. Recruitment took place from 2016-2019. Early treatment was defined as initiation of ART prior to 12 months of age, at a CD4 percentage greater than 15% in children ages 12 months to 60 months, or a CD4 count greater than 350 cell/mm3 for children 60 months or older. Logistic regression models were used to evaluate the association between potential risk factors and seizures. Results: We identified 73 children with new-onset seizure and compared them to 254 control children with HIV but no seizures. Early treatment with antiretroviral therapy was associated with a significant reduction in the odds of seizures (OR 0.04, 95% CI 0.02—0.09; p
Læs mere Tjek på PubMedNGUMBAU, Nancy M.; NEARY, Jillian; WAGNER, Anjuli D; ABUNA, Felix; OCHIENG, Ben; DETTINGER, Julia C; GÓMEZ, Laurén; MARWA, Mary M.; WATOYI, Salphine; NZOVE, Emmaculate; PINTYE, Jillian; BAETEN, Jared M.; KINUTHIA, John; JOHN-STEWART, Grace
Journal of Acquired Immune Deficiency Syndromes, 8.12.2023
Tilføjet 8.12.2023
Background: Oral PrEP and male partner HIV self-testing (HIVST) is being scaled up within antenatal clinics (ANC). Few data are available on how co-distribution influences acceptance of both interventions. Methods: We utilized data from the PrIMA (NCT03070600) trial in Kenya. Women included in this analysis were determined to be at high risk of HIV and offered oral PrEP and partner HIVST. Characteristics were compared between women who chose: 1) PrEP and HIVST, 2) HIVST-alone, 3) PrEP-alone, or 4) declined both (reference), excluding women who had partners known to be living with HIV. Results: Among 911 women, median age was 24 years, 87.3% were married, 43.9% perceived themselves to be at high risk of HIV and 13.0% had history of intimate partner violence (IPV). Overall, 68.9% accepted HIVST and 18.4% accepted PrEP with 54.7% accepting HIVST-alone, 4.2% PrEP-alone and 14.3% both HIVST and PrEP. Of women accepting HIVST, partner HIV testing increased from 20% to 82% and awareness of partner HIV status increased from 4.7% to 82.0% between pregnancy and 9-months postpartum (p
Læs mere Tjek på PubMedFeelemyer, Jonathan; Bershteyn, Anna; Scheidell, Joy D.; Brewer, Russell; Dyer, Typhanye V; Cleland, Charles M; Hucks-Ortiz, Christopher; Justice, Amy; Mayer, Ken; Grawert, Ames; Kaufman, Jay S.; Braithwaite, Scott; Khan, Maria R
Journal of Acquired Immune Deficiency Syndromes, 8.12.2023
Tilføjet 8.12.2023
Background Background Given the disproportionate rates of incarceration and lower life expectancy (LE) among Black sexual minority men (BSMM) and Black transgender women (BTW) with HIV, we modeled the impact of decarceration and screening for psychiatric conditions and substance use on LE of US BSMM/BTW with HIV. Methods We augmented a microsimulation model previously validated to predict LE and leading causes of death in the US with estimates from the HPTN 061 cohort and the Veteran’s Aging Cohort Studies. We estimated independent associations among psychiatric and substance use disorders, to simulate the influence of treatment of one condition on improvement on others. We used this augmented simulation to estimate LE for BSMM/BTW with HIV with a history of incarceration under alternative policies of decarceration (i.e., reducing the fraction exposed to incarceration), screening for psychiatric conditions and substance use, or both. Results Baseline LE was 61.3 years. Reducing incarceration by 25%, 33%, 50%, and 100% increased LE by 0.29 years, 0.31 years, 0.53 years, and 1.08 years, respectively, versus no reductions in incarceration. When reducing incarceration by 33% and implementing screening for alcohol, tobacco, substance use, and depression, in which a positive screen triggers diagnostic assessment for all psychiatric and substance use conditions and linkage to treatment, LE increased by 1.52 years compared to no screening or decarceration. Discussion LE among BSMM/BTW with HIV is short compared with other people with HIV. Reducing incarceration and improving screening and treatment of psychiatric conditions and substance use could substantially increase LE in this population. Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Læs mere Tjek på PubMedBrooks, Hannah L.; Graves, Erin; De Schacht, Caroline; Emílio, Almiro; Matino, Ariano; Aboobacar, Arifo; Audet, Carolyn M.
Journal of Acquired Immune Deficiency Syndromes, 8.12.2023
Tilføjet 8.12.2023
Walle, A. D., Hunde, M. K., Demsash, A. W.
BMJ Open, 8.12.2023
Tilføjet 8.12.2023
ObjectiveTo assess healthcare providers’ intentions and the associated factors to use mobile phone-based short message service (SMS) to support adherence and care of tuberculosis (TB) patients in the Oromia region of southwest Ethiopia. Study designAn institutional-based cross-sectional study was conducted from October to November 2022. Study settingThe study was conducted in public hospitals which include Mettu Karl referral hospital, Dembi Hospital, Bedelle Hospital, Darimu Hospital and Chora Hospital in Ilu Aba Bor and Buno Bedelle zones. ParticipantsA total of 625 (54.9% male and 45.1% female) health professionals participated in the study. The study participants were selected using a simple random sampling technique. All health professionals permanently working in Ilu Aba Bor and Buno Bedelle zone hospitals were included in this study. However, health professionals with less than 6 months of experience and those who were not present during the data collection period were excluded from this study. Outcome measureThe intention to use mobile phone-based SMS to support TB patients. ResultsHealthcare professionals’ intention to use mobile SMS was 54.4%. Effort expectancy had a significant direct effect on attitude (β=0.162, p
Læs mere Tjek på PubMedLawrence, K., Fibert, P., Hobbs, J., Myrissa, K., Toribio-Mateas, M. A., Quadt, F., Cotter, P. D., Gregory, A. M.
BMJ Open, 8.12.2023
Tilføjet 8.12.2023
IntroductionCurrent interventions for children with attention-deficit/hyperactivity disorder (ADHD) are primarily medication, behavioural therapy and parent training. However, research suggests dietary manipulations may provide therapeutic benefit for some. There is accumulating evidence that the gut microbiome may be atypical in ADHD, and therefore, manipulating gut bacteria in such individuals may help alleviate some of the symptoms of this condition. The aim of this study is to explore the effects of supplementation with kefir (a fermented dairy drink) on ADHD symptomatology, sleep, attention and the gut microbiome in children diagnosed with ADHD. Methods and analysisA 6-week randomised, double-blind, placebo-controlled trial in 70 children aged 8–13 years diagnosed with ADHD. Participants will be recruited throughout the UK, through support groups, community groups, schools, social media and word of mouth. Children will be randomised to consume daily either dairy kefir or a placebo dairy drink for 6 weeks. The primary outcome, ADHD symptomatology, will be measured by The Strengths and Weakness of ADHD-symptoms and Normal-behaviour scale. Secondary outcomes will include gut microbiota composition (using shotgun metagenomic microbiome sequencing), gut symptomatology (The Gastrointestinal Severity Index questionnaire), sleep (using 7-day actigraphy recordings, The Child’s Sleep Habits Questionnaire and Sleep Self Report questionnaire), inattention and impulsivity (with a computerised Go/NoGo test). Assessments will be conducted prior to the intervention and at the end of the intervention. Interaction between time (preintervention/postintervention) and group (probiotic/placebo) is to be analysed using a Mixed Model Analysis of Variances. Ethics and disseminationEthical approval for the study was granted by St Mary’s University Ethics Committee. Results will be disseminated through peer-reviewed publications, presentations to the scientific community and support groups. Trial registration numberNCT05155696.
Læs mere Tjek på PubMedFortuna, D., Caselli, L., Berti, E., Moro, M. L.
BMJ Open, 8.12.2023
Tilføjet 8.12.2023
ObjectivesWe aimed to provide a region-wide comprehensive account of the indirect effects of COVID-19 on patients with chronic disease, in terms of non-COVID-19 mortality, and access to both inpatient and outpatient health services over a 2-year pandemic period. DesignPopulation-based retrospective study. SettingAdult patients, affected by at least 1 of 32 prevalent chronic conditions, residing in the Emilia-Romagna Region in Italy, during the years 2020 (N=1 791 189, 47.7% of the overall adult regional population) and 2021 (N=1 801 071, 47.8%). ResultsOverall, non-COVID-19 mortality among patients with chronic disease during the pandemic (2.7%) did not differ substantially from the expected mortality (2.5%), based on a 3 years prepandemic period (2017–2019) and adjusting for the demographic and clinical characteristics of the population under study. Indeed, while the first pandemic wave was characterised by a significant non-COVID-19 excess mortality (March: +35%), the subsequent phases did not show such disruptive variations in non-COVID-19 deaths, which remained around or even below the excess mortality threshold. End-of-life care of patients with chronic disease, especially for non-COVID-19 cases, significantly shifted from hospitalisations (–19%), to homecare (ADI: +7%; w/o ADI: +9%). Overall, healthcare of patients without COVID-19 chronic disease decreased, with similar negative trends in hospitalisations (–15.5%), major procedures (–19.6%) and ER accesses (–23.7%). Homecare was the least affected by the pandemic, with an overall reduction of –9.8%. COVID-19 outbreak also impacted on different types of outpatient care. Rehabilitation therapies, specialist visits, diagnostic and lab tests were considerably reduced during the first pandemic wave and consequent lockdown, with access rates of patients without COVID-19 chronic disease below –60%. ConclusionsThis work thoroughly describes how a large and well-defined population of patients without COVID-19 chronic disease has been affected by the changes and reorganisation in the healthcare system during 2 years of the pandemic, highlighting health priorities and challenges in chronic disease management under conditions of limited resources.
Læs mere Tjek på PubMedBinyaruka, P., Mtenga, S. M., Mashasi, I., Karugu, C. H., Mohamed, S. F., Asiki, G., Mair, F. S., Gray, C. M.
BMJ Open, 8.12.2023
Tilføjet 8.12.2023
BackgroundPeople with type 2 diabetes (T2D) are at increased risk of poor outcomes from COVID-19. Vaccination can improve outcomes, but vaccine hesitancy remains a major challenge. We examined factors influencing COVID-19 vaccine uptake among people with T2D in two sub-Saharan Africa countries that adopted different national approaches to combat COVID-19, Kenya and Tanzania. MethodsA mixed-methods study was conducted in February-March 2022, involving a survey of 1000 adults with T2D (500 Kenya; 500 Tanzania) and 51 in-depth interviews (21 Kenya; 30 Tanzania). Determinants of COVID-19 vaccine uptake were identified using a multivariate logistic regression model, while thematic content analysis explored barriers and facilitators. ResultsCOVID-19 vaccine uptake was lower in Tanzania (26%) than in Kenya (75%), which may reflect an initial political hesitancy about vaccines in Tanzania. People with college/university education were four times more likely to be vaccinated than those with no education (Kenya AOR=4.25 (95% CI 1.00 to 18.03), Tanzania AOR=4.07 (1.03 to 16.12)); and people with health insurance were almost twice as likely to be vaccinated than those without health insurance (Kenya AOR=1.70 (1.07 to 2.70), Tanzania AOR=1.81 (1.04 to 3.13)). Vaccine uptake was higher in older people in Kenya, and among those with more comorbidities and higher socioeconomic status in Tanzania. Interviewees reported that wanting protection from severe illness promoted vaccine uptake, while conflicting information, misinformation and fear of side-effects limited uptake. ConclusionCOVID-19 vaccine uptake among people with T2D was suboptimal, particularly in Tanzania, where initial political hesitancy had a negative impact. Policy-makers must develop strategies to reduce fear and misconceptions, especially among those who are less educated, uninsured and younger.
Læs mere Tjek på PubMedWang, M., Hu, M., Wang, Y., Long, C., Xia, Y., Zhu, D., Zhao, W., Yuan, B., He, P.
BMJ Open, 8.12.2023
Tilføjet 8.12.2023
ObjectiveAlthough the herpes zoster vaccine has been available in mainland China since June 2020, residents’ knowledge of herpes zoster and the herpes zoster vaccine is poor, and vaccination rates are low, especially among the elderly, who are at high risk for herpes zoster. This study assessed willingness to be vaccinated against herpes zoster and factors associated with vaccination among urban residents in China. MethodsA mixed-methods study was conducted in community health centres from August 2022 to September 2022. We used convenience sampling to select 2864 residents from 9 Chinese cities for the quantitative study and 67 adults for the qualitative study. A structured questionnaire was used for the quantitative study, and data were collected through face-to-face interviews. Multinomial logistic regression was used to analyse factors associated with willingness to vaccinate. Qualitative data were analysed using thematic analysis of barriers to herpes zoster vaccination. ResultsA total of 2864 eligible respondents were included in the study. Of these, 42.67% intended to receive the herpes zoster vaccine, 21.44% refused and 35.89% were hesitant. The results of the quantitative and qualitative analyses showed that the factors associated with respondents’ willingness to be vaccinated against herpes zoster included: personal characteristics such as gender, age and income; knowledge and attitudes about herpes zoster and the vaccine; vaccine characteristics such as efficacy, safety and price; and other factors such as pain tolerance and accessibility to vaccination. ConclusionThe low willingness to vaccinate, especially among the elderly, is mainly related to their poor knowledge and negative attitude towards the infection and vaccination. Therefore, health education about herpes zoster, immunisation promotion, and improvement of accessibility and affordability would be valuable in China.
Læs mere Tjek på PubMedBMC Infectious Diseases, 8.12.2023
Tilføjet 8.12.2023
Abstract Background To ensure emergency infection prevention and control (IPC) can be fully supervised and monitored in coronavirus disease (COVID-19) epidemic period, a three-level inspector mechanism called "Internal self-check, Departmental cross-check, and Verification of outstanding key and difficult issues" was established in southwest China. The present study aimed to explore the effectiveness of inspector mechanism for the emergency IPC. Methods A self-control real-world study was conducted during COVID-19 epidemic period from 2020 to 2022. An innovative designed mobile phone application was used to realize paperless information transmission and data management. Data were compared between inspection levels using SPSS 19.0 software. Results A total of 2,800,132 supervision records were collected, including 149,137 comprehensive epidemic IPC projects, 1,410,093 personal protective equipment (PPE) use, 1,223,595 wearing and removing process of PPE and 17,307 ultraviolet light-detectable fluorescent (UV/F) surface marker. During the study period, the inspectors and subjects explored many optimized IPC measures. The compliance rate of check items has exceeded 98%, and internal self-check has a statistically significant higher rate than departmental cross-check (99.95% versus 98.74%, χ2 = 26111.479, P < 0.001). Compare with the failure rate in internal self check, the failure rate of PPE usage and wearing/removing process was statistically higher in departmental cross-check (χ2 = 1957.987, P < 0.001, χ2 = 465.610, P < 0.001, respectively). The overall clearance rate of UV/F surface markers is 87.88%, but there is no statistically significant difference over the three years of the present study (F = 2.902, P = 0.071). Conclusions Inspector mechanism for the emergency IPC completed an incredible inspection workload and offered creative assistance to combat the COVID-19 outbreak. These methods and accumulated experiences should be helpful for us to strengthen IPC for future epidemic.
Læs mere Tjek på PubMedBMC Infectious Diseases, 8.12.2023
Tilføjet 8.12.2023
Abstract Purpose To examine the clinical characteristics of adult patients with community-acquired spontaneous bacterial meningitis (CASBM) with a fulminant clinical course. Materials and methods The clinical features and therapeutic outcomes of 127 adult CASBM patients were analyzed. The patients were divided into two groups as those with and without a fulminant clinical course. Fulminant clinical course was defined as meningitis presenting initially with marked consciousness disturbance (Glasgow Coma Scale score
Læs mere Tjek på PubMedJon Cohen
Science, 7.12.2023
Tilføjet 7.12.2023
Mitch Leslie
Science, 7.12.2023
Tilføjet 7.12.2023
Pelle T. Petersen, Jacob Bodilsen, Micha P. G. Jepsen, Lykke Larsen, Merete Storgaard, Jannik Helweg‐Larsen, Lothar Wiese, Birgitte R. Hansen, Hans R. Lüttichau, Christian Ø. Andersen, Henrik Nielsen, Christian T. Brandt, The Danish Study Group of Infections of the Brain (DASGIB)
Journal of Medical Virology, 7.12.2023
Tilføjet 7.12.2023
Rachael M. Milwid, Michael Li, Aamir Fazil, Mathieu Maheu‐Giroux, Carla M. Doyle, Yiqing Xia, Joseph Cox, Daniel Grace, Milada Dvorakova, Steven C. Walker, Sharmistha Mishra, Nicholas H. Ogden
Journal of Medical Virology, 7.12.2023
Tilføjet 7.12.2023
Peng Ge, Yalan Luo, Jie Liu, Jin Liu, Haiyun Wen, Guixin Zhang, Hailong Chen
Journal of Medical Virology, 7.12.2023
Tilføjet 7.12.2023
Austin Zygmunt, Andrea Saunders, Christine Navarro, Maan Hasso, Shannon Collinson
Journal of Medical Virology, 7.12.2023
Tilføjet 7.12.2023
Sandhya Hora, Prabhjyoti Pahwa, Hamda Siddiqui, Anoushka Saxena, Minal Kashyap, Jayesh K. Sevak, Ravinder Singh, Maryam Javed, Pushpa Yadav, Pratibha Kale, Gayatri Ramakrishna, Meenu Bajpai, Asmita Rathore, Jaswinder S. Maras, Shakun Tyagi, Shiv K. Sarin, Nirupama Trehanpati
Journal of Medical Virology, 7.12.2023
Tilføjet 7.12.2023
Wen Tian, Yuanyuan Zhang, Shuying Geng, Jianxin Wang, Wenjuan Ji, Yanli Xu, Xu Gao, Xin Li, Ling Lin, Yuanni Liu, Chuan Song, Zhihai Chen, Wei Zhang
Journal of Medical Virology, 7.12.2023
Tilføjet 7.12.2023
Talía Malagón, Aline Lopes Ribeiro, Emily Montosa Nunes, Tarik Gheit, Mariam El‐Zein, Luisa L. Villa, Eduardo L. Franco, Laura Sichero
Journal of Medical Virology, 7.12.2023
Tilføjet 7.12.2023
Rui Song, Xiaoyou Chen, Baoliang Li, Jun Ni, Yunao Zhou, Hongbin Zhang, Xiao Liang, Liangfeng Zou, Juan Liu, Fang Yang, Guangyu Li, Xiaodi Guo, Zhe Liu, Fengfeng Mao, Cong Lei, Jianhua Sui, Wenhui Li, Ronghua Jin
Journal of Medical Virology, 7.12.2023
Tilføjet 7.12.2023
Fu Li, Xiaona Shen, Huijuan Zhang, Haoyuan Jin, Lin Zhang, Bing Lv, Weihong Li, Zhichao Liang, Xin Zhang, Daitao Zhang, Xuexin Hou, Yang Pan, Biao Kan, Quanyi Wang
Journal of Medical Virology, 7.12.2023
Tilføjet 7.12.2023
Nora Heber, Bianca J. Kuhn, Tobias D. Strobel, Claudia Lohrey, Jeroen Krijgsveld, Karin Hoppe‐Seyler, Felix Hoppe‐Seyler
Journal of Medical Virology, 7.12.2023
Tilføjet 7.12.2023
Theofano Panayiotou, Marios Eftychiou, Eleutherios Patera, Vasilis J. Promponas, Katerina Strati
Journal of Medical Virology, 7.12.2023
Tilføjet 7.12.2023
Jinyoung Yang, Hye‐Jin Kim, Jun‐Won Kim, Jin Yang Baek, Young Jae Lee, Ju‐yeon Choi, Su‐Hwan Kim, Hyeonji Jeong, Eun Joo Chung, Gi‐eun Rhie, Byoung Kwon Park, So‐Young Lee, Kyong Ran Peck, Byoungguk Kim, Jae‐Hoon Ko
Journal of Medical Virology, 7.12.2023
Tilføjet 7.12.2023
Marica Grossegesse, Daniel Stern, Natalie Hofmann, Rebecca Surtees, Claudia Kohl, Janine Michel, Andreas Nitsche
Journal of Medical Virology, 7.12.2023
Tilføjet 7.12.2023
Sujith Baliga, Vedat Yildiz, Rahul Barve, Alexander Farag, Priyanka Bhateja, Emile Gogineni, Darrion Mitchell, David Konieczkowski, John Grecula, Sung Jun Ma, Simeng Zhu, Xuefeng Liu, Marcelo Bonomi, Dukagjin M. Blakaj
Journal of Medical Virology, 7.12.2023
Tilføjet 7.12.2023
Infection, 7.12.2023
Tilføjet 7.12.2023
Abstract Purpose The oral cavity and, in particular, potential oral foci might pose a risk of periprosthetic joint infection (PJI). The aim of this cohort study was to determine whether practical preoperative dental screening would reduce the prevalence of early PJI in the first month after surgery. Methods Patients attending a specialized endoprosthesis implantation clinic between 2018 and 2022 were recruited. Two groups were examined. The test group consisted of patients attending the clinic between 2020 and 2022 and who were referred to their family dentist using a standardized form. The comparison group consisted of patients who were treated in the clinic between 2018 and 2020. They were not referred to their family dentist. The two groups were compared for the prevalence of PJI. Univariate analysis followed by multiple logistic regression was performed to confirm risk factors for PJI in this cohort. Results 2560 individuals (test group: 1227, comparison group: 1333) were included. The prevalence of PJI was significantly lower in the test group (0.8% vs. 1.8%, p = 0.04). Multiple logistic regression with PJI as the dependent variable showed that a dental referral was a strong predictor of a lower prevalence of PJI (OR: 0.43, CI95 0.205–0.917, p = 0.03). Male gender was also strongly associated with a higher frequency of PJI (OR: 2.68, CI95 1.32–5.42, p = 0.01). Age (OR: 1.06, CI95 1.01–1.10, p = 0.01) and BMI (OR: 1.11, CI95 1.05–1.17, p
Læs mere Tjek på PubMedInfection, 7.12.2023
Tilføjet 7.12.2023
Abstract Respiratory syncytial virus (RSV) inflicts severe illness and courses of infections not only in neonates, infants, and young children, but also causes significant morbidity and mortality in older adults and in people with immunosuppression, hemato-oncologic disease, chronic lung disease, or cardiovascular disease. In June and August 2023, effective vaccines against RSV were approved for the first time by the European Medicines Agency (EMA) for the EU. The respective pivotal studies showed a very high efficacy of the vaccine in preventing severe RSV-associated respiratory infections. At this point, use of the respective vaccines is restricted to persons aged 60 years or older, according to the registration studies. We therefore recommend use of the vaccination in persons aged 60 years or older. In addition, we recommend use of the vaccination in adults of any age with severe pulmonary or cardiovascular pre-existing conditions, as well as in adults with significant immune compromise, after individual consultation with the treating physician. Cost coverage can be applied for individually with the responsible health insurance company.
Læs mere Tjek på PubMedJuan P. Aguilar Ticona, Meng Xiao, Dan Li, Nivison Nery, Matt Hitchings, Emilia M. M. Andrade Belitardo, Mariam O. Fofana, Renato Victoriano, Jaqueline S. Cruz, Laise Eduarda Paixão de Moraes, Icaro Morais Strobel, Jessica Jesus Silva, Ananias Sena do Aragão Filho, Guilherme S. Ribeiro, Mitermayer G. Reis, Federico Costa, Ricardo Khouri, Albert I. Ko, Derek A.T. Cummings
International Journal of Infectious Diseases, 7.12.2023
Tilføjet 7.12.2023
The Omicron variant of SARS-CoV-2 has been characterized by high levels of immune evasion [1]. The most recently emerged subvariants, BQ.1.1 and XBB, have been shown to effectively evade immunity generated by vaccines, including bivalent formulations designed specifically to target Omicron BA.5 [1-3]. In addition to diminishing vaccine effectiveness, the continued evolution of Omicron variants may limit the utility of available treatment options such as Nirmatrelvir/ritonavir or molnupiravir [4, 5].
Læs mere Tjek på PubMedEva ZanditenasSerge AnkriDepartment of Molecular Microbiology, Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
Virulence, 7.12.2023
Tilføjet 7.12.2023
Ma Junyong, Yizhou Wang, Jian Liu, Yali Wu, Shichao Zhang, Xifeng Li, Daoxi Zha, Jun Zhou, Yong Xia, Xiaofeng Zhang
International Journal of Infectious Diseases, 7.12.2023
Tilføjet 7.12.2023
The COVID-19 virus (SARS-CoV-2) has been spreading globally for over three years, posing a serious threat to human life and health, and causing significant impacts on surgical procedures. Early surgical research on COVID-19 primarily focused on the effects of infection on postoperative complications and the timing of surgeries. In Wuhan, China, where the initial infections of SARS-CoV-2 occurred, all infected surgical patients developed pulmonary complications shortly after surgery, with 44.1% (15/34) requiring ICU care, and the mortality rate reaching 20.5% [1].
Læs mere Tjek på PubMedZhiwei HuangXinyi YangYi JinJicheng YuGuoying CaoJingjing WangYingying HuJingyi DaiJufang WuQiong WeiYan TianShuyan YuXu ZhuXiaomeng MaoWei LiuHong LiangShansong ZhengYunfei JuZenghua WangJing ZhangXiaojie Wu1Phase I Clinical Research Center, Huashan Hospital, Fudan University, Shanghai, China2Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China3Research Ward of Huashan Hospital, Fudan University, Shanghai, China4Qilu Pharmaceutical Co. Ltd., Jinan, China, James E. Leggett
Antimicrobial Agents And Chemotherapy, 7.12.2023
Tilføjet 7.12.2023
Yu, J.-S., Kim, E.-S., Park, K. S., Lee, Y. J., Park, Y. C., Nam, D., Kim, E.-J., Ha, I.-H.
BMJ Open, 7.12.2023
Tilføjet 7.12.2023
ObjectivesFibromyalgia treatment trends vary globally; however, the trend in South Korea has not been investigated yet. This study aimed to analyse the fibromyalgia treatment trends in South Korea. DesignRetrospective, observational study using serial cross-sectional data. SettingThe National Patient Samples of the Korean Health Insurance Review & Assessment Service from 2011 to 2018 were used. ParticipantsA total of 31 059 patients with fibromyalgia were included in this study. The basic characteristics of the patients were stratified by sex, age and comorbidity. A patient was considered to have a condition if it was recorded as a principal diagnosis at least once in a year. Primary and secondary outcome measuresTrends in the types of medical visits and prescribed treatments were investigated and the values are presented as rates per 100 patients. The types of pharmacological treatment were presented according to the existing clinical guidelines. Additionally, combination prescription trends and associated characteristics were investigated. ResultsOf the patients, 66.2% were female. Visits to internal medicine departments showed the most significant increase (2011: 11.34; 2018: 21.99; p
Læs mere Tjek på PubMedAmerican Journal of Tropical Medicine and Hygiene, 7.12.2023
Tilføjet 7.12.2023
Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 109 Issue: 6 Pages: 1207-1208
Læs mere Tjek på PubMedAmerican Journal of Tropical Medicine and Hygiene, 7.12.2023
Tilføjet 7.12.2023
Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 109 Issue: 6 Pages: 1209-1210
Læs mere Tjek på PubMedAmerican Journal of Tropical Medicine and Hygiene, 7.12.2023
Tilføjet 7.12.2023
Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 109 Issue: 6 Pages: 1211-1212
Læs mere Tjek på PubMedAmerican Journal of Tropical Medicine and Hygiene, 7.12.2023
Tilføjet 7.12.2023
Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 109 Issue: 6 Pages: 1213-1219
Læs mere Tjek på PubMedAmerican Journal of Tropical Medicine and Hygiene, 7.12.2023
Tilføjet 7.12.2023
Journal Name: The American Journal of Tropical Medicine and Hygiene Volume: 109 Issue: 6 Pages: 1220-1222
Læs mere Tjek på PubMed